US SB4867 | 2019-2020 | 116th Congress

Status

Spectrum:
Status: Introduced on October 26 2020 - 25% progression, died in committee
Action: 2020-10-26 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award grants to eligible entities to support research on and facilitate access to investigational drugs that diagnose or treat ALS. The Food and Drug Administration shall award grants to public and private entities to cover the costs of research and development of drugs that diagnose or treat ALS and other severely debilitating neurodegenerative diseases. HHS shall also establish the Collaborative for Neurodegenerative Diseases, which shall support the development and regulatory approval of drugs that address ALS and other rare neurodegenerative diseases.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Accelerating Access to Critical Therapies for ALS Act

Sponsors


History

DateChamberAction
2020-10-26SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

Same As/Similar To

HB7071 (Related) 2020-06-01 - Referred to the House Committee on Energy and Commerce.
HB8662 (Same As) 2020-10-23 - Referred to the House Committee on Energy and Commerce.

Subjects


US Congress State Sources


Bill Comments

feedback